Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

• Rosatom
• Russia
• International Atomic Energy Agency
• United States
• Canada
• CANDU reactor
• Germany
• Australia
• South Korea
• European Union
• Research reactor
• Europe
• Iodine-131
• Medicine
• South Africa
• Netherlands
• Radium
• Neoplasm
• Physiology
• Leukemia
• Clinical trial
• Lutetium
• Health care
• Chemotherapy
• Physician
• Melanoma
• Personalized medicine

Source: Nucnet

Date: Friday, 14 April 2023

Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Read more ...

Thirty-five years on from the Chernobyl accident, Ukraine and the International Atomic Energy Agency (IAEA) have highlighted their commitment to cooperation in nuclear power. Meanwhile Ukraine’s nuclear regulator has launched the start of operations at a new storage facility for used nuclear fuel at the Chernobyl site.  

• Russia
• United Kingdom
• International Atomic Energy Agency
• France
• Canada
• Germany
• Ukraine
• Japan
• Spent nuclear fuel
• European Union
• Chernobyl Nuclear Power Plant
• Europe
• Finland
• Switzerland
• Sweden
• Italy
• Belgium
• Medicine
• Denmark
• Belarus
• Netherlands
• X-ray
• Norway
• Coronavirus disease 2019
• COVID-19 pandemic
• Kyiv

Source: World Nuclear News

Date: Wednesday, 28 April 2021

Original article: world-nuclear-news.org/Articles/Title

Read more ...

The Advancing Nuclear Medicine consortium, led by the Nuclear Research and Consultancy Group (NRG), has been awarded a EUR6.8 million (USD7.7 million) subsidy to develop FIELD-LAB. This Dutch initiative is aimed at accelerating the development and introduction of new radiopharmaceuticals.

• Medicine
• Netherlands

Source: World Nuclear News

Date: Friday, 18 January 2019

Original article: world-nuclear-news.org/Articles/NRG-receives-funding-for-nuclear-medicine-R-D-cent

Read more ...